In breast cancer, ctDNA frequently contains driver alterations in PIK3CA, ESR1, TP53, and ERBB2, alongside copy-number changes and methylation patterns that reflect molecular subtypes [37,38]. This evidence concerns the gene ERBB2 and breast cancer.